- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Nanostart AG has, with effect from October 1, 2010, appointed HSBC Trinkaus & Burkhardt, part of the HSBC Group, as a new Designated Sponsor.
With some 300,000 employees and 8,000 office locations across 87 countries, HSBC Group is one of the world's largest banking and financial services organizations. Within Germany, its subsidiary HSBC Trinkaus & Burkhardt is one of the country's leading and longest established private banks. Its staff of 2,295 serves private, corporate and institutional clients from seven office locations throughout Germany. With a "AA" rating from Fitch (confirmed in December 2009), the bank is the highest rated private commercial bank in Germany.
As Designated Sponsor, HSBC Trinkaus will provide liquidity to the ongoing trading of the company's shares on the XETRA system through binding bid and offer quotes. In addition, HSBC will assist the company in its efforts to reach out to investors, in Germany and around the world.
"The expertise and worldwide network which HSBC Trinkaus offers as part of a major global banking group makes it, as Designated Sponsor, an ideal partner for a globally expanding company such as Nanostart," explained Marco Beckmann, CEO of Nanostart AG.
Mark Kahlenberg, head of corporate broking at HSBC Trinkaus, added: "We look forward to working with Nanostart AG as an international investment company in one of the strongest growing sectors."
Close Brothers Seydler AG will continue to serve as a Designated Sponsor for Nanostart shares alongside HSBC Trinkaus.
About Nanostart AG
Nanostart AG, headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government.
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.
For more information, please click here
Dr. Hans Joachim Dürr
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 122
Copyright © Nanostart AGIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
BESSTECH Announces $250K Investment from Eastern New York Angels : Funding will accelerate commercialization of BESSTECH’s innovative lithium-ion battery electrode technology and enable hiring of key personnel May 13th, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015